If you experience side effects or plateaus, we adjust your treatment plan accordingly
Tirzepatide is a dual GIP and GLP-1 receptor agonist licensed in the UK for type 2 diabetes mellitus treatment The most common side effects are gastrointestinal, including nausea, diarrhoea, vomiting, constipation, and abdominal discomfort The medication slows gastric emptying and reduces appetite, which may contribute to digestive symptoms Seek urgent medical attention for severe abdominal pain, persistent vomiting, signs of dehydration, or allergic reactions Report suspected side effects to the MHRA through the Yellow Card scheme Table of Contents Are Hiccups a Side Effect of Mounjaro
Zepbound (Tirzepatide) As a GLP-1 and GIP dual agonist, Zepbound enhances weight loss results and may benefit patients not responding to single-agonist treatments
& Tschpe, C
Team proudP Jul 22, 2025 8 min read Updated: Sep 2, 2025 A Closer Look at GLP-1 Medications in Recent Research There is growing interest in how GLP-1 medications, which were originally developed for diabetes and obesity, might relate to prostate cancer
(2015) reported the following in association with GHK-Cu use [5]: Tightening of skin Improves skin elasticity and firmness Improve skin density Reduced deep wrinkles and fine lines Reduced hyperpigmentation and sun damage GHK-Cu for Healing GHK-Cu has potential uses as a healing agent
